Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

News of restrictions placed on federal health agencies has been met with public outcry and prompted the spread of ...

Kansas health officials are tackling the largest tuberculosis (TB) outbreak in U.S. history, with 67 confirmed cases since the start of 2025. The outbreak inclu ...